Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Has announcements × pomalidomide × Clear all

Phase

Status

Completed 3 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Carboplatin 17 Cisplatin 14 pembrolizumab 13 Pemetrexed 11 Nivolumab 11 Gemcitabine 11 durvalumab 10 Rituximab 10 Paclitaxel 9 Dexamethasone 7 osimertinib 6 olaparib 6 Prednisone 6 Lenalidomide 6 trastuzumab deruxtecan 5 amivantamab 5 acalabrutinib 5 Specimen Handling 5 Docetaxel 5 Cyclophosphamide 5 Capecitabine 5 Bortezomib 5 Bevacizumab 5 tremelimumab 4 niraparib 4 lazertinib 4 daratumumab 4 cabozantinib 4 atezolizumab 4 abemaciclib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05083169 2026-04-13

MajesTEC-3

Janssen Research & Development, LLC

Phase 3 Active not recruiting

587 enrolled 2 FDA

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡